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Inductive reciprocal signaling between mesenchymal and adjacent epithelia gives rise to skin appendages such as hair follicles and mammary
glands. Lef1-mediated canonical Wnt signaling is required for morphogenesis of these skin appendages during embryogenesis. In order to define
the role of canonical Wnt signaling during early embryonic mammary gland development, we determined the temporal and spatial changes in Wnt
signaling during embryogenesis in wild-type and Lef1-deficient embryos harboring a Tcf/Lef1-βgal reporter (TOPGAL) transgene. In contrast to
previous studies using TOPGAL mice from a distinct founder, we observe that Wnt signaling acts initially on mesenchymal cells associated with
the sequential appearance of mammary placodes. As placode development progresses between 12.5 and 15.5 dpc, Wnt signaling progressively
accumulates in the mammary epithelial compartment. By 18.5 dpc, βgal activity is confined to mesenchymal and epithelial cells near the nipple
region. In Lef1-deficient embryos, the transition of Wnt signaling from mesenchyme to the mammary epithelia is blocked for placodes #1, 4 and 5
despite the expression of Tcf1 in epithelial cells. These placodes ultimately disappear by 15.5 dpc, while placodes 2 and 3 typically did not form in
the absence of Lef1. Progressive loss of placodes 1, 4, and 5 is accompanied by increased apoptosis in mesenchymal cells adjacent to the
mammary epithelial placodes. While factors important for embryonic mammary gland development, such as FGF7, are expressed normally in
Lef1-deficient animals, one mediator of the Hedgehog (Hh)-signaling pathway is aberrantly expressed. Specifically, Shh, Ihh, and Gli2 are
expressed in mammary epithelial cells at levels in Lef1-deficient animals similar to wild-type littermates. However, the signal for Ptc-1 is strongly
reduced in mesenchymal cells surrounding the mammary placode in Lef1 mutants relative to wild-type embryos. The loss of Ptc-1, both a receptor
for and transcriptional target of Hh signaling, suggests that Hh signaling is blocked in Lef1-deficient embryos. Thus, these data reveal distinct
requirements of different mammary placodes for Lef1-dependent Wnt signaling. They further define dynamic changes in which cells integrate
Lef1-dependent Wnt signaling during progression of embryonic mammary gland development.
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Embryonic mammary gland development is dependent on
reciprocal inductive interactions between the mesenchyme and
overlying ectoderm (Cunha, 1994; Pispa and Thesleff, 2003;
Robinson et al., 1999; Sakakura et al., 1987). Signals
originating in the mesenchyme have been proposed to specify
ectodermal cells to form epithelial mammary placodes
(Sakakura, 1987). Reciprocal signaling from the placodes to⁎ Corresponding author. Fax: +1 416 978 5959.
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doi:10.1016/j.ydbio.2006.03.030the underlying mesenchyme then directs condensation of
fibroblasts which form the mammary mesenchyme. Mainte-
nance of these reciprocal signals stimulates further prolifera-
tion and differentiation of the placodes resulting in the
development of the primitive mammary ductal tree present at
birth.
Murine mammary gland formation initiates near 10.5 dpc
with the appearance of the mammary line along the anterior–
posterior axis on both sides of the ventral flank of the embryo
(Sakakura, 1987; Turner and Gomez, 1933; Veltmaat et al.,
2004). These structures give rise to five symmetric pairs of
mammary placodes elevated above the surrounding surface
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developing simultaneously, placodes appear in the order of pair
number 3, then 4, followed by 5 and 1, and finally pair number 2
(Mailleux et al., 2002). These epithelial spherical placodes
subsequently invaginate into the underlying dermal mesen-
chyme forming mammary buds (Robinson et al., 1999;
Sakakura et al., 1987). In males, the epithelial bud becomes
separated from the epidermis under the influence of testosterone
by active induction of apoptosis by the mammary mesenchyme
(Wysolmerski et al., 1998). In females, at 15.5 dpc, the buds
elongate and form a mammary sprout, the distal tip of which
breaks through the primary mammary mesenchyme and
penetrates a secondary mesenchyme, the underlying fat pad
precursor mesenchyme. The mammary mesenchyme induces
nipple formation in the overlying epidermis at around 16.5 dpc
(Foley et al., 2001). Meanwhile, the epithelial sprout branches
into the fat pad precursor mesenchyme, resulting in the
formation of a rudimentary ductal tree.
Lymphocyte enhancer factor-1 (Lef1) is one of the earliest
known markers defining formation of the mammary placode
(Mailleux et al., 2002; van Genderen et al., 1994). Lef1 is an
architectural protein chaperoning a number of distinct factors
controlling transcription of target genes. In the context of the
canonical Wnt-signaling cascade, complexes of Lef1 and the
transcriptional repressors, such as Groucho, are replaced by
Lef1-β-catenin-containing complexes, resulting in activated
transcription of Wnt-target genes (Behrens et al., 1996; Eastman
and Grosschedl, 1999).
The canonical Wnt-signaling pathway is important for
placode induction and differentiation of mammary epithelium
(Hennighausen and Robinson, 2001; Smalley and Dale, 2001).
A role for Wnt-induced signaling in mammary bud develop-
ment is supported by studies of transgenic mouse embryos
bearing βgal reporter gene under the control of Lef/Tcf-
dependent promoter (Chu et al., 2004; DasGupta and Fuchs,
1999; Veltmaat et al., 2004). During the early stages of
mammary development, the mammary line is defined by the
expression of Wnt10b which becomes localized to the placodes
(Veltmaat et al., 2004). Lef1 is expressed in the epithelial cells of
the mammary buds at 12 dpc and is subsequently induced in the
condensed mesenchyme surrounding each bud by 15 dpc during
embryogenesis (Foley et al., 2001). Induction of Lef1
expression in the mammary mesenchyme is dependent on
paracrine signaling from the mammary epithelium by the
secreted protein, PTHLH, and its receptor, PTHR1 (Foley et al.,
2001). Defective mammopoeisis arises in Lef1-deficient
animals; embryos initially exhibit a reduced number of
mammary buds and aborted development of those which do
form (van Genderen et al., 1994). In contrast, total inhibition of
Wnt signaling by targeting Dickkopf-1 to epithelium cues
inhibition of mammary bud formation at 11.5 dpc (Andl et al.,
2002; Chu et al., 2004).
In order to understand the early genetic events contributing
to mammary placode formation, we (i) characterized the
expression of the Tcf/Lef1-family proteins, (ii) determined the
spatial and temporal induction by canonical Wnt signaling of
specific embryonic mammary cells, and (iii) characterizedalterations in Wnt signaling in Lef1-deficent embryos. Our data
reveal that Wnt signaling first stimulates mesenchymal cells
and progressively signals epithelial cells of the developing
mammary placode. However, in the absence of Lef1, this switch
fails to occur, Wnt signaling remaining confined to the
mesenchymal cells as mammary placode development is
aborted. Furthermore, we present evidence that Lef1-mediated




The generation and genotyping of mutant and transgenic mice were
described previously: Lef1 (Galceran et al., 1999; van Genderen et al., 1994);
TOPGAL mice (Cheon et al., 2002) were maintained on C57Bl/6 background.
These mice contain a βgalactosidase gene (βgal) downstream of a c-fosminimal
promoter and three consensus TCF-binding motifs. TOPGAL/Lef1+/−mice were
crossed to generate TOPGAL/Lef1−/− embryos.
Analysis of βgalactosidase activity
Whole embryos, embryonic ventral skin or adult number 4 inguinal
mammary glands were fixed with 4% paraformaldehyde for 1 h, rinsed and
washed with Rinse solution A (0.1 M PBS pH 7.4, 2 mMMgCl2, 5 mM EGTA)
for 30 min, then rinsed and washed with Rinse solution B (0.1 M PBS, 2 mM
MgCl2, 0.01% sodium deoxycholate, 0.02% Tween) for 5 min and then
transferred into Tissue Stain Base solution (Specialty Media) with Xgal substrate
at a final concentration of 2 mg/ml. Staining was performed in the dark at 37°C
overnight. Samples were photographed and/or paraffin-embedded, sectioned,
and counterstained with eosin. Mammary gland whole mounts were counter-
stained with 0.2% carmine, 0.5% aluminum potassium sulfate.
Whole-mount in situ hybridization (ISH) and immunohistochemistry
(IHC)
Embryos were fixed in 4% paraformaldehyde (PFA) overnight at 4°C. For
whole mounts, embryos were dehydrated serially to 100% methanol, treated for
5 h with 1:5 hydrogen peroxide in methanol and rehydrated to PBST at room
temperature. Whole-mount in situ hybridizations were performed with
digoxigenin-labeled antisense riboprobes as described previously (Motoyama
et al., 1998a). The cDNA for probes for Lef1 (Hudson et al., 1998), Tcf1
(Korinek et al., 1998b), Tcf3 (image clone 444295), Tcf4 (image clone 774951),
Gli2 and Gli3 (Mo et al., 1997), Ptc1 (Motoyama et al., 1998a).
Immunohistochemical analysis of embryo sections was performed according
to the instructions provided in the R&D HRP-AEC immunostaining kits, with
the following amendments. Antigen retrieval was performed using 10 M sodium
citrate solution, pH 6, preheated for 3 min, and then sections were microwaved
for 10 min. Primary antibodies for androgen receptor (rabbit polyclonal, Dr. Gail
Prins, The University of Illinois, Chicago, Illinois), BrdU (Becton Dickson), β-
catenin (610154, BD Biosciences Pharmingen), or Ptc-1 (G-19; Santa Cruz)
were incubated overnight at 4°C. All sections were counterstained with
hematoxylin (Vector). Whole-mount images were taken by using a Nikon DXM
1200 digital camera driven by Nikon ACT-1 imaging software. Sections were
photographed using a Q Imaging Fast 1394 cooled CCD camera and compiled
using Simple PCI software (Nikon).
BrdU and TUNEL labeling
For BrdU-labeling experiments, pregnant mice were injected with 0.1 mg
BrdU/g body weight, and embryos were collected after 2 h and processed as
described (Motoyama et al., 1998b). For apoptosis studies, an ApoAlert DNA
fragmentation assay kit (Clonetech) was used according to the manufacturer's
directions.
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Canonical Wnt signaling is active during mammary gland
development
Members of the Lef1/Tcf-family proteins integrate develop-
mental signals from the canonical Wnt-signaling pathway. We
first assessed by whole-mount in situ hybridization the
expression pattern of these factors during early embryonic
mammary gland development (Fig. 1). At 12.5 dpc, during the
early stages of mammary placode development, both Tcf1 and
Tcf3 are expressed in the mammary epithelium, while Tcf4 is
expressed in the surrounding mesenchyme. In addition to the
Lef1/Tcfs, their co-factor β-catenin is also upregulated in the
mammary region, as described previously (Chu et al., 2004 and
Fig. 1E).
In order to determine which cells are influenced by the
canonical Wnt-signaling pathway during mammary gland
development, we employed previously described animals
harboring a transgene responsive to canonical Wnt signaling
(Cheon et al., 2002). The TOPGAL transgene encodes a
concatemer of three Tcf/Lef1 binding sites upstream of the
minimal c-fos promoter and a βgalactosidase (βgal) reporter
gene. Fig. 2 illustrates the dynamic changes in Wnt signaling
during mammary gland morphogenesis. In TOPGAL embryos,
βgal activity is apparent in the AER at 11.0 dpc. Shortly
afterwards (11.25–12 dpc), a streak of βgal-positive cells isFig. 1. Expression of nuclear effectors of the canonical Wnt-signaling pathway
in the embryonic mammary gland. Whole-mount in situ hybridization analysis
demonstrates the expression of Lef1 (A), Tcf1 (B), Tcf3 (C), Tcf4 (D) and (E) β-
catenin at 12.5 dpc in developing mammary placodes. Lef1, Tcf1, and Tcf3 are
localized to the epithelial placode, while Tcf4 is localized to the surrounding
mesenchyme. Scale bar = 500 μm.apparent adjacent to the developing forelimb bud, slightly
posterior to its proximal aspect. This streak continues to expand
around the limb bud, coincident with the appearance of βgal
expression around the first mammary placode to form, placode
3 (Fig. 2E). At this stage, βgal expression is confined to the
mesenchymal cells surrounding the epithelial placode (Fig. 3A).
Strong expression is evident several hours later in all placodes
(placodes 1 and 5 behind the limb bud) with the similar intense
mesenchymal staining. Canonical Wnt signaling in the
mesenchymal cells is supported by the presence of β-catenin
in the nuclei of cells surrounding the epithelial placode (Fig.
3E). As placode development continues (13.5 dpc onwards),
βgal activity appears progressively more intense within the
epithelial cells during mammary bud development (Figs. 2H–J
and Fig. 3B). By 14.5 dpc (Fig. 2I), strong βgal activity is
detected in both the epithelial and mesenchymal cells of the
developing mammary buds. Strong expression persists at
15.5 dpc (Figs. 2J and 3C).
Between 16.5 dpc and birth, morphogenesis of the mammary
bud gives rise to a rudimentary ductal tree. By 18.5 dpc, βgal
activity is confined to a discrete region at the origin of this
primitive mammary gland. Whole-mount analysis (Figs. 2K–L)
and section (Fig. 3D) revealed that mesenchymal cells
surrounding the nipple region and the primary duct as well as
epithelial cells of the primary ducts proximal to the developing
nipple region appear βgal-positive. During postnatal develop-
ment, βgal activity was not detected during adolescent
development (data not shown) but became apparent during
mid-pregnancy (12 dpc) and is prominent by 15.5 dpc within
the epithelial cells of the developing alveoli (Fig. 2 M). βgal
activity persisted in these structures until birth (data not shown).
Taken together, these data reveal dynamic alterations in cells
affected by canonical Wnt signaling at distinct stages of
mammary gland development. Importantly, both mesenchymal
and epithelial cells are involved in signaling through this
pathway. Mesenchymal cells signal first during the early stages
of placode development, while signaling in epithelial cells
progressively increases as the mammary bud develops further.
Lef1 is not required for induction of mammary placodes 1, 4,
and 5
Previous studies demonstrated that the transcriptional
mediator of canonical Wnt signaling, Lef1, is necessary for
development of skin appendages, including the mammary gland
(Foley et al., 2001; Mailleux et al., 2002; van Genderen et al.,
1994). In order to define the basis for the mammary gland defect
associated with loss of Lef1, we characterized the morphology
and histology of mammary placodes in Lef1-deficient embryos
harboring the TOPGAL reporter transgene. Histological
analysis of serial sections from Lef1−/− embryos at 13.5 dpc
(Fig. 4C) and 15.5 dpc (Fig. 4G) demonstrates that the mutant
placodes are smaller and fail to invaginate into the dermis,
remaining elevated above the surface of the embryo (Figs. 4A
and E, respectively). Relative to wild-type mammary buds, the
mesenchyme of the dermis is populated with fewer cells but
clearly express mesenchymal markers specific for the mammary
Fig. 2. Wnt-signaling activity during mammary gland development. TOPGAL expression demonstrates epithelial and mesenchymal Wnt activity during mammary
gland development. (A) Mammary placodes arise asynchronously, with placode pair number 3 detected first, followed by number 4, then numbers 1 and 5, and finally
pair number 2 (Veltmaat et al., 2003). Whole-mount X-gal stained TOPGAL embryos from 11 dpc to 15.5 dpc (B–J). Cells expressing TOPGAL appear blue.
TOPGAL-positive cells first appear in a ring of cells around mammary placode 3 at 11.75 dpc (E). By 12 dpc (F), a ring of blue-stained cells surround all mammary
placodes. Note increasing TOPGAL activity in the mesenchyme surrounding the forelimb bud in region of placodes 2 and 3 (double arrowheads). Blue-stained cells
are seen as a ring around (G) 12.5 dpc placodes. By 13.5 dpc, blue stained cells are visible within the epithelial cells of the bud and remain until 15.5 dpc (H–J). X-gal
stained whole-mount of 18.5 dpc ventral skin showing localized staining around nipple region (K). Whole-mount of X-gal and carmine aluminum (red)-stained
18.5 dpc mammary gland (L). Whole-mount of X-gal and carmine aluminum (red)-stained mammary gland from TOPGAL transgenic mouse on day 15 of pregnancy
(M). Scale bar in panels B–K—500 μm; scale bar in panel L—100 μm; scale bar in panel M—25 μm.
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Fig. 3. Changes in Wnt-signaling activity during embryonic mammary gland development. Cross-sections through mammary bud 4 from 12.5–15.5 dpc embryos. At
12.5 dpc (A), mesenchymal cells stained blue with low levels of TOPGAL expression in the epithelial bud. From 13.5 dpc (B) to 15.5 dpc (C), epithelial cells show an
increase in transgene expression. Mesenchymal cells continue to express the transgene. (D) At 18.5 dpc, TOPGAL expression is evident in mammary mesenchyme
surrounding the nipple region and in the primary duct. Immunohistochemical analysis demonstrates β-catenin expression is apparent in the nucleus of mesenchymal
cells of the mammary bud at 15.5 dpc in wild-type (E) and Lef1−/− (F) embryos. In wild-type embryos, weak cytoplasmic and nuclear expression is evident. In contrast,
strong cell membrane localization is apparent in Lef1−/− embryos. Scale bar in panels A–D—50 μm; scale bar in panels E–F 25 μm.
223K. Boras-Granic et al. / Developmental Biology 295 (2006) 219–231gland, such as androgen receptor (Figs. 4D and H). Analysis of
serial sections of embryonic skin from Lef1-deficient female
embryos beyond 15.5 dpc failed to detect any mammary
rudiments (data not shown).
While mammary placodes are not observed in Lef1−/−
embryos older than 15.5 dpc (van Genderen et al., 1994 and
data not shown), development of a variable number of
placodes is initiated in these embryos. At 12.5 dpc, a single
auxiliary bud (placode 1) and both inguinal buds (placodes 4
and 5) are detected in the majority of Lef1−/− embryos,
whereas five pairs of mammary placodes are clearly visible in
wild-type embryos (Figs. 5A–B, placodes 1 and 5 not shown).
Control TOPGAL and/or TOPGAL/Lef1+/− embryos show
βgal reporter activity in the mammary mesenchyme underlying
the developing mammary placodes at 12.5 dpc as expected. In
TOPGAL/Lef1−/− embryos, βgal activity is evident in the
mammary mesenchymal cells surrounding epithelial placodes
1, 4, and 5 (Fig. 5B). However, in contrast to wild-type
embryos, localized TOPGAL activity in the region of placodes
2 and 3 was either completely or almost completely absent at12.5 dpc. As development progresses from 13.5 dpc onward,
Wnt signaling localizes to the mammary epithelium in wild-
type embryos (Figs. 5C and E). In contrast, Wnt signaling
remains restricted to the mesenchyme of Lef1−/− mammary
placodes 1, 4, and 5 at 13.5 dpc. βgal expression is also
detected in a broad band between the fore and hind limbs, a
zone of signaling not evident in wild-type embryos (Fig. 5D).
By 14.5 dpc, when βgal expression levels are strong in both
the epithelial and mesenchymal cells of wild-type mammary
buds (Figs. 2I, 3C and 5E), βgal remains restricted primarily to
mesenchymal cells of the Lef1−/− placodes (Fig. 5F). In
addition, βgal expression is no longer visible along the flank
between the fore limbs and hind limbs as seen at 13.5 dpc in
Lef1−/− embryos. Supporting the persistence of βgal expres-
sion in mesenchymal cells of the placodes in Lef1−/− embryos
is the location of β-catenin protein. Specifically, in cells of the
mesenchyme, where βgal activity is observed, β-catenin is
expressed in the nucleus whereas cell membrane staining in the
epithelial cells of wild-type (Fig. 3E) and mutant placodes is
detected (Fig. 3F).
Fig. 4. Arrested mammary gland formation in Lef1-null embryos. Histological analysis of wild-type (A) 13.5 dpc and (E) 15.5 dpc mammary buds, and Lef1-deficient
(C) 13.5 dpc and (G) 15.5 dpc mammary buds. Mammary mesenchymal-specific expression of androgen receptor in control (B and F) and Lef1−/− (D and H) embryos.
Histological sections A, C, E, and G were stained with hematoxylin and eosin. Note the control mammary bud penetrates the dermis and is surrounded by several layers
of mammary mesenchymal cells. The mutant bud fails to invaginate further and is surrounded by fewer mesenchymal cells. Scale bar—50 μm.
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Wnt signaling in the mesenchyme, the absence of Lef1 is
required for the transition of Wnt signaling to the adjacent
epithelial placodes. Lack of this transition precedes the
disappearance of mammary placodes 1, 4, and 5.
Lef1 is an important mesenchymal survival factor
Arrested development of Lef1-deficient placodes and their
subsequent regression suggests that defects in cell proliferation
and/or apoptosis may result due to the loss of Lef1 activity. We
characterized cell proliferation, determined by BrdU incorpo-ration, and apoptosis, determined in TUNEL assays, in
mammary buds or placodes of wild-type and Lef1−/− mice. In
Lef1-null mammary placodes, active cell proliferation is
apparent at 13.5 dpc (data not shown) and 14.5 dpc, by
bromodeoxyuridine (BrdU) incorporation (Figs. 6A–B). Both
the epithelial and mesenchymal compartments of the mammary
buds stain-positive relative to wild-type embryos. Therefore,
arrested placode development does not appear to be due to
defective proliferation of cells within the placode itself.
To further explore the cellular mechanism responsible for the
failure of mammary gland development, we investigated
whether Lef1 is critical for survival of epithelial and/or
Fig. 5. Deregulated epithelial Wnt signaling in Lef1−/− embryos. TOPGAL expression in wild-type (A, C, and E) and Lef1−/− (B, D, and F) embryos between 12 dpc
and 14.5 dpc. Cells expressing the TOPGAL transgene appear blue. At 12.5 dpc, TOPGAL expression in Lef1−/− embryos (B) reveals formation of placodes 1, 4 and 5
as compared to 5 pairs in control embryos (A) (pairs 1 and 5 not shown). Strong TOPGAL expression is detected in mesenchymal cells surrounding the placodes. By
13.5 dpc (C and D), epithelial cells of the bud also show X-gal staining. Note the strong X-gal staining in Lef1−/− embryos along the flank between the forelimb and
placode 4 not seen in wild-type embryos. At 14.5 dpc, TOPGAL expression is strong in both the epithelial and mesenchymal cells of the mammary bud in wild-type
embryos (E). However, in Lef1−/− buds, TOPGAL expression is mainly in mesenchymal cells of the bud (H). Insets in E and F are magnification of bud 4. Scale bar—
250 μm.
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apoptotic activity between Lef1−/− and control mammary buds
(Figs. 6C–G). In Lef1−/− embryos, TUNEL analysis demon-
strates significant staining of mesenchymal cells underlying the
mutant placodes, while no detectable cell death is observed in
female control embryos at 14.5 dpc. Apoptosis appears in the
mesenchymal cells of the dermis underlying the mutant
placodes at 14.5 dpc. By 15.5 dpc, TUNEL staining is
indistinguishable between wild-type and Lef1-deficient embryos
at a point when the mutant placodes have begun to disappear.
Hedgehog-signaling pathway is disrupted in the absence of
Lef1
Analysis of tooth and hair development in Lef1-deficient
embryos revealed that Hedgehog (Hh) signaling is lost
(DasGupta and Fuchs, 1999; Gat et al., 1998; Niemann et al.,2002; Zhou et al., 1995). Although the role of the Hh signaling
in mammary gland development remains uncharacterized,
members of the Hh-signaling pathway have been implicated
in the regulation of mammary gland morphogenesis (Lewis
et al., 1999; Michno et al., 2003). We determined, therefore,
whether the loss of Lef1 altered the expression pattern of
members of the Hh-signaling pathway (Figs. 7 and 8). Despite
being expressed at relatively low levels, whole mount analysis
for Shh and Ihh showed no difference in their levels of
expression in Lef1-deficient mammary placodes compared to
wild-type embryos (data not shown; see also Michno et al.,
2003). We determined that another soluble factor shown
previously to be important in mammary gland development,
FGF7, was expressed in the mammary placodes of Lef1-
deficient mice similar to their wild-type counterparts (Figs. 7A–
B). Furthermore, alterations in the expression the downstream
mediator of Hh signaling, Gli2, appear not to be significantly
Fig. 6. Increased apoptosis of mammary mesenchymal cells in the absence of Lef1. BrdU incorporation was used to determine cell proliferation in (A) control and (B)
Lef1-defcient embryos at 14.5 dpc. Epithelial cells in both buds stain positive for BrdU incorporation. However, the mesenchymal cells in Lef1-null embryos show a
complete absence of cells stained with anti-BrdU. TUNEL assays performed on sections of mammary placodes taken from control (C, E (female) and F (male)) and
Lef1 knockout embryos (D and G) at 14.5 dpc and 15.5 dpc, respectively. During 14.5 dpc, mutant buds are positive for apoptosis in dermal mesenchymal cells
underlying the mammary bud. Control females are negative, while control males are positive (indicative of male mammary regression). By 15.5 dpc, the mesenchyme
underlying mutant buds is no longer positive for apoptosis. Scale bar—50 μm.
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and, independently, on sections of 14.5 dpc embryos (Figs. 7E–
F), Gli2 is detected in epithelial cells of both wild-type
mammary buds and mutant placodes. In contrast to these
factors, which are expressed principally in the mammary
epithelia, Ptc-1 expression appears strongly reduced in the
mesenchyme of Lef1-deficient mice (Fig. 8). In situ analysis of
sections (Figs. 8A–B) shows a strong reduction in the apparent
level of Ptc-1 message in Lef1-deficient placodes, whereas
robust expression is seen in wild-type littermates. Further
characterization of the level of expression was performed by
immunohistochemical detection of Ptc-1 protein (Figs. 8C–D).
While some expression of Ptc-1 is seen in the epithelial cells of
both wild-type and mutant mammary buds or placodes,
respectively, signal for Ptc-1 protein in the surrounding
mesenchyme in Lef1-deficient embryos approaches background
levels, while strong expression is evident in the mesenchyme of
wild-type embryos. Since Ptc1 is both a mediator and target of
the Hh-signaling pathway, these basal levels of Ptc1 expression
are consistent with a loss of Hh signaling in mammary glands of
Lef1-deficient embryos.Taken together, these data reveal dynamic alterations in Wnt
signaling between mesenchymal and epithelial aspects of the
embryonic mammary placode. These changes depend specifi-
cally on the expression of Lef1 and, in its absence, result in
apoptosis of the mammary mesenchyme and regression of
mammary epithelial placodes.
Discussion
Lef1 is required for embryonic mammary gland develop-
ment, although details of the effectors and downstream events it
coordinates in the mammary gland remain undefined. Expres-
sion of Lef1 is dynamic during mammary gland morphogenesis
being initially restricted to the epithelial compartment of the
mammary placode. Subsequently, it is also detected in the pri-
mary mesenchymal cells underlying the mammary bud (Foley
et al., 2001; Mailleux et al., 2002); K. Boras, unpublished
observation). Lack of Lef1 expression reveals a central role for
this mediator of canonical Wnt signaling in both early
specification of the placodes (placodes 2 and 3) and progression
of their development (placodes 1, 4, and 5).
Fig. 7. FGF7 andGli2 are expressed in Lef1-deficient mammary placodes. At 14.5 dpc, transcripts for FGF7 (A and B) andGli2 (C–F) are detected in wild-type (A, C,
and E) and Lef1-deficient (B, D, and F) embryos. Both FGF7 andGli2 are expressed in the mammary placodes of mutant embryos at levels indistinguishable from that
of wild-type mammary buds. Scale bar in panels A–C—250 μm; scale bar in panel D—100 μm; scale bar in panels E–F—50 μm.
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gland, we have been able to establish a potential hierarchy in
mediating early embryonic mammary gland development (Fig.
9). Specifically, development of the embryonic mammary gland
is dependent on reciprocal epithelial–mesenchymal signaling.
Our data reveal that Wnt-signaling activity involves both
mesenchymal and epithelial aspects of the developing embry-
onic mammary gland. Lef1, Tcf1, and Tcf3 are expressed in the
epithelial placode and bud, whereas Tcf4 is detected in the
adjacent mesenchyme, consistent with recent studies detecting
Tcf1, Tcf3, and Tcf4 in the mammary buds by RT-PCR (Chu
et al., 2004). Furthermore, β-catenin expression is localized to
the cell membrane of the epithelial placode and to the nucleus of
cells in the adjacent mesenchyme when βgal activity in
TOPGAL mice is restricted to the mesenchyme. During
14.5 dpc and 15.5 dpc, when Wnt activity is apparent in the
mesenchyme and the epithelium, β-catenin is localized to the
nucleus in both cell types.These data suggest that mesenchymal cells are the first to
integrate Wnt signals during early stages of mammary gland
development. Progression of development is accompanied by
induction of Wnt signaling in the epithelial compartment of the
developing mammary bud. In the absence of Lef1, Wnt
signaling remains confined to the mesenchyme, and develop-
ment is halted at the placode stage. These data suggest that
epithelial-specific Lef1 activity may be required during
mammary placode maturation at the point where the placode
descends into the dermis, although the observed mesenchymal-
specific cell death in Lef1-deficient mammary placodes does
not allow us to preclude a role for Lef1 in the mesenchyme.
Tissue recombination studies in whisker follicles and tooth in
Lef1-deficient mutants demonstrated previously compartment-
specific Lef1-dependent events in their development (Kratoch-
wil et al., 1996). Whisker follicle development requires, for
example, both epithelial and mesenchymal Lef1 activity,
whereas tooth development is dependent on epithelial-specific
Fig. 8. Loss of expression of Ptc-1 in Lef1-deficient mammary placodes. Expression of Ptc-1 in wild type (A and C) and Lef1-deficient (B and D) was determined by in
situ detection of Ptc-1 message (A and B) or Ptc-1 protein (C and D). Expression for Ptc-1 message is strongly reduced in mutant embryos. Immunohistochemical
analysis of Ptc-1 reveals further that Ptc-1 expression is close to background in the mesenchyme of Lef1-deficient mammary placodes while strong expression in the
mesenchyme is evident in wild-type mammary mesenchyme (e—mammary epithelia; m—mammary mesenchyme). Scale bar in panels A and B—100 μm; scale bar
in panels C and D—15 μm.
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dissect the requirements for Lef1 in specific tissue compart-
ments of the developing mammary gland.
Our data indicate that, while other members of the Tcf/
Lef1-family are involved in specific stages of early mammaryFig. 9. Model of functional roles of genes during mammary gland development.
requirements for Lef1. For placodes 2 and 3 in the mouse, placode initiation depends o
stage (12.5 dpc): formation of individual mammary epithelial placodes is associate
specifically be mediated by the mesenchymally expressed Tcf4. In the absence of Lef1
is associated with a failure of Wnt signaling to switch from being exclusively mes
activation of the Hh-signaling pathway is blocked at this stage in the absence of Lef
Lef1 expression. This requirement is not compensated for by the expression of othegland development, they do not exhibit completely over-
lapping activities. In both wild-type and Lef1-deficient
embryos, mesenchymal Wnt signaling is apparent, suggesting
that Tcf4 may mediate the canonical Wnt pathway for
placodes 1, 4, and 5 at this stage. Subsequently, epithelial(i) Placode initiation (11.5 dpc): induction of different placodes has distinct
n Lef1 while for placodes 1, 4, and 5, Lef1 expression is not required (ii) placode
d with Wnt signaling in the adjacent mesenchyme. Here, the Wnt signal may
, development of placodes 1, 4, and 5 arrests. Failure to progress to the bud stage
enchymal to both the epithelial and mesenchymal compartments. Furthermore,
1. (iii) Bud stage (14.5 dpc): Epithelial-specific Wnt-signaling activity requires
r Tcfs in mammary epithelial or mesenchymal cells.
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Tcf1 and Tcf3, the latter two also expressed in the epithelial
placode. However, we detected Tcf1 in the epithelial cells of
Lef1-deficient placodes (data not shown). It is clear, therefore,
that Tcf1 does not act redundantly with Lef1 at this stage of
mammary gland development. Indeed, the presence of Tcf1 in
Lef1-deficient placodes supports the notion that it may
regulate canonical Wnt-signaling gene targets which are
distinct from those regulated by Lef1. Tcf1-, Tcf3-, and Tcf4-
deficient embryos have not been reported to exhibit
mammary gland defects during embryogenesis (Korinek
et al., 1998a; Merrill et al., 2004; Verbeek et al., 1995). Thus, at
some stages of development, redundant activities of the
Tcf/Lef1 family compensating for the lack of specific Tcf/Lef1
family members may occur. A more detailed study of the
expression pattern and activities of the Tcf/Lef1 family
proteins during specific stages of mammary gland develop-
ment will be required to determine their precise roles in this
tissue.
During embryonic mammary gland formation, placode pairs
initiate in specified positions and order. Expression of Lef1 in
wild-type embryos demonstrated placodes initiate in the order
of pair 3, then 4, followed by 5 and 1 and finally pair 2
(Mailleux et al., 2002 and data not shown). While loss of Lef1 in
mice results in a complete arrest of mammary gland
development (van Genderen et al., 1994), we demonstrated
that Lef1−/− embryos display defects in placode initiation and in
placode progression. Morphological and histological analysis of
Lef1-deficient embryos reveals that the initiation of the five
placode pairs is variable. Placode pairs 1, 4, and 5 always
initiate, while placodes 2 and 3 are only occasionally observed
and always as individual placodes rather than in pairs.
Interestingly, the first (placode 3) and last (placode 2) placode
pairs to develop are absent in Lef1−/− embryos. Although these
placodes are spatially localized to one another, their formation is
temporally distant. Based on gene targeting studies, individual
placodes appear to develop independently of one another or via
different cellular/molecular mechanisms (Davenport et al.,
2003; Mailleux et al., 2002; Schimmang et al., 1992). It is
possible that development of each placode may have different
genetic requirements. The mechanism of temporal and spatial
localization of placode pairs is uncharacterized and mechanis-
tically unexplored (reviewed in Veltmaat et al., 2003).
While our results suggest defective initiation of placodes 2
and 3, the defect for placodes 1, 4, and 5 in Lef1-deficient
animals is placode progression. All placodes initiating in these
animals arrest early in development (around 13.5 dpc). Both the
epithelium (p63, K14, E-cadherin-positive, K. Boras, unpub-
lished observation) and the mesenchyme (androgen receptor,
see Fig. 4) express cell-specific markers demonstrating that
specification of the mammary placode is normal. These data
suggest that epithelial–mesenchymal interactions required for
placode induction and mammary mesenchymal condensation
are intact in the absence of Lef1. However, by 14.5 dpc, Wnt
activity in the mammary epithelium of Lef1−/− placodes is
blocked. We propose, therefore, that this signal is needed to
respond to and integrate the adjacent underlying mesenchymalsignals. The epithelium either fails to respond to the received
mesenchymal signal and/or to instruct the adjacent mesenchy-
mal cells to develop further.
We suggest that one result of deregulated reciprocal
signaling is the loss of a survival factor instructing the
mesenchyme. In Lef1−/− embryos, we detect TUNEL-positive
cells in the underlying dermis adjacent to the mutant buds. Also
known as the secondary mesenchyme, these cells give rise to the
fat pad precursor. It is unclear, however, if apoptosis in these
cells contributes to the failure of mammary gland development
and subsequent regression. The mechanism underlying the
condensation of the fat pad precursor is unclear, although it
occurs as the bud approaches this tissue suggesting regulation
by reciprocal tissue interactions. Gene targeting studies indicate
differentiation of this mesenchyme is required for bud
development (Satokata et al., 2000). For example, targeted
deletion ofMsx2 (Satokata et al., 2000) or Fgf10 (Mailleux et al.,
2002; Sakaue et al., 2002), genes expressed during the
development of the fat pad precursor, result in mammary bud
arrest before sprout elongation (15 dpc).
Our data characterizing the expression of factors in the Hh-
signaling pathway suggest that loss of Hh signaling may
contribute to the failure of the mammary placodes in Lef1-
deficient animals to progress. The role of Hh signaling during
embryonic mammary gland development is not well character-
ized. Analysis of embryonic mammary gland development
determined that Shh and Ihh are expressed in the mammary
placode (Gallego et al., 2002; Michno et al., 2003). Further-
more, members of the Hh-signaling pathway including Gli2,
Gli3, and Ptc1 are expressed in the mammary placode (Veltmaat
et al., 2003; Figs. 7, 8 and data not shown). Loss individually of
Shh or Ihh expression has no apparent effect on mammary gland
development in embryos due, apparently to their redundant
activities (Gallego et al., 2002; Michno et al., 2003). Embryonic
defects in mammary glands have not been noted for either Gli1
or Gli2, although in embryos homozygous for the Gli3xt (extra
toes) allele, mammary placodes 3 and 5 are not induced (A.
DeMaximy, J. Veltmaat and S. Bellusci, unpublished results
cited in Lewis and Veltmaat, 2004; Mailleux et al., 2002). As
expression of Shh in both hair and tooth development has been
shown to require Lef1 expression (Gat et al., 1998; Kratochwil
et al., 2002; Zhou et al., 1995), loss of Lef1 in the embryonic
mammary gland is consistent with deregulation of the Hh
pathway in this skin appendage. We observed that the
transcriptional regulators of Hh signaling, Gli2, are aberrantly
expressed in Lef1−/− placodes and that the expression of the Hh-
ligand receptor, Ptc1, is strongly reduced. As a target of Hh
signaling, low levels of Ptc1 expression are suggestive that the
Hh pathway is inactive. Since expression of Shh and Ihh are
detected in Lef1−/− placodes (data not shown), we propose that
Ptc1 may be a downstream target of Lef1/Wnt-signaling
pathway.
Our results detecting Wnt signaling in cells of the developing
embryonic mammary gland contradict those previously
reported (Chu et al., 2004). This latter group employed animals
(designated here as TOPGAL-F) harboring a Tcf/Lef1-βgal
reporter transgene which appears to be identical to the one used
230 K. Boras-Granic et al. / Developmental Biology 295 (2006) 219–231to generate the animals we employed (designated here as
TOPGAL-C (Cheon et al., 2002; Staal et al., 2001)). In
TOPGAL-F animals, Wnt signaling was detected exclusively in
epithelial cells of the developing placode; no βgal expression
was observed in the adjacent mesenchymal cells nor were
alterations in Wnt signaling reported. For both TOPGAL-F and
TOPGAL-C animals, no βgal activity was observed for either
mouse in the mammary gland during puberty, and βgal activity
was lost specifically in the mammary placode at 16.5 dpc where
development halts just prior to sprout formation. However, 2
days later during embryogenesis, divergent Wnt signaling arises
again; epithelial staining detected in the primitive ductal tree in
TOPGAL-F embryos, while we observed in the TOPGAL-C
embryos restricted βgal expression in the mesenchyme and
primary ducts at the nipple region. Other differences in
expression were also observed for all skin appendages.
Specifically, we did not detect βgal activity in the developing
whiskers and hair follicles, a pattern distinct from that of the
TOPGAL-F mouse. Given the expression pattern we observed
for TOPGAL-C animals in our study, we sought to ensure that
an additional marker could support the pattern of Wnt-signaling
activity. The presence of nuclear β-catenin is required for
canonical Wnt signaling. Thus, we determined that when
mesenchymal-specific activity of βgal is detected, β-catenin is
present in the nucleus of mammary mesenchymal cells.
Likewise, when Wnt signaling switches to the epithelial
placode, β-catenin staining at cell junctions is difficult to detect
while intracellular staining is more prominent. However, in the
absence of Lef1, β-catenin strongly stains the cell junctions in
the epithelial placode, consistent with the lack of Wnt signaling
observed. We propose, therefore, that the different transgenic
TOPGAL animals read out signaling of distinct Wnt ligands
through specific Frizzled receptors. Indeed, we suggest that
these and other TOPGAL founders may be invaluable tools in
revealing specific Wnt/Frizzled signaling cascades in tissues
whose development is influenced by this complex family of
developmental factors.
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